Antipodes Partners LTD Walgreens Boots Alliance, Inc. Transaction History

Antipodes Partners LTD

$2.72 Billion
Q2 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$32.33 - $37.71 $36.2 Million - $42.2 Million	1,118,671 Added 51.1%	3,307,927 $114 Million
Q4 2022 Feb 08, 2023	BUY	$30.52 - $41.79 $9.96 Million - $13.6 Million	326,273 Added 17.51%	2,189,256 $81.8 Million
Q3 2022 Nov 10, 2022	SELL	$31.4 - $42.04 $8.65 Million - $11.6 Million	-275,580 Reduced 12.89%	1,862,983 $58.5 Million
Q2 2022 Aug 12, 2022	SELL	$37.9 - $46.81 $8.39 Million - $10.4 Million	-221,440 Reduced 9.38%	2,138,563 $81.1 Million
Q1 2022 Apr 21, 2022	BUY	$44.77 - $54.33 $5.32 Million - $6.46 Million	118,885 Added 5.3%	2,360,003 $106 Million
Q4 2021 Jun 07, 2022	BUY	$43.72 - $52.25 $49.8 Million - $59.6 Million	1,139,720 Added 103.48%	2,241,118 $117 Million
Q4 2021 Apr 21, 2022	SELL	$43.72 - $52.25 $50.1 Million - $59.9 Million	-1,146,837 Reduced 51.01%	1,101,398 $54.9 Million
Q4 2021 Feb 14, 2022	SELL	$43.72 - $52.25 $18.3 Million - $21.8 Million	-418,126 Reduced 15.68%	2,248,235 $112 Million
Q3 2021 Nov 15, 2021	BUY	$45.58 - $51.78 $3.56 Million - $4.04 Million	78,094 Added 3.02%	2,666,361 $125 Million
Q2 2021 Aug 17, 2021	BUY	$50.84 - $56.8 $20 Million - $22.4 Million	393,764 Added 17.94%	2,588,267 $136 Million
Q1 2021 May 13, 2021	BUY	$41.16 - $55.05 $43.6 Million - $58.3 Million	1,059,285 Added 93.31%	2,194,503 $120 Million
Q4 2020 Feb 16, 2021	BUY	$33.52 - $44.1 $30.6 Million - $40.2 Million	912,018 Added 408.61%	1,135,218 $45.3 Million
Q3 2020 Nov 10, 2020	BUY	$34.67 - $43.16 $7.74 Million - $9.63 Million	223,200 New	223,200 $8.02 Million

Others Institutions Holding WBA

# of Institutions

1,073

Shares Held

512M

Call Options Held

19.7M

Put Options Held

24.4M

View Full List

About Walgreens Boots Alliance, Inc.

Ticker WBA
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 864,812,992
Market Cap $7.79B
Description
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products...

More about WBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Antipodes Partners LTD, based on Form 13F filings with the SEC.

News

Stay updated on Antipodes Partners LTD with notifications on news.

Account